SCHEMBL3208857

SCHEMBL3208857

Cc1ccc(-c2cccc3c2O[C@@H](CN)CN3)c(C(F)(F)F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.34
PDE3B Q13370 8/20 0.33
PDE3A Q14432 8/20 0.33
PRKAB2 O43741 2/20 0.32
PRKAG1 P54619 2/20 0.32
PRKAA2 P54646 2/20 0.32
PRKAA1 Q13131 2/20 0.32
PRKAG3 Q9UGI9 2/20 0.32
PRKAG2 Q9UGJ0 2/20 0.32
PRKAB1 Q9Y478 2/20 0.32
PLK4 O00444 1/20 0.32
ROCK2 O75116 1/20 0.32
NTRK1 P04629 1/20 0.32
MET P08581 1/20 0.32
ROS1 P08922 1/20 0.32
RPS6KB1 P23443 1/20 0.32
EPHA2 P29317 1/20 0.32
AXL P30530 1/20 0.32
FLT4 P35916 1/20 0.32
FLT3 P36888 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3197216 1.00 KDR (0.34) KDRPDE3BPDE3APRKAB2PRKAG1
SCHEMBL3218091 1.00 KDR (0.34) KDRPDE3BPDE3APRKAB2PRKAG1
SCHEMBL3203171 0.88 KMT2A (0.37) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3208851 0.88 KMT2A (0.37) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3212211 0.88 KMT2A (0.37) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3217903 0.88 HTR1A (0.36) PDE3BPDE3APRKAB2PRKAG1PRKAA2
SCHEMBL3213826 0.88 HTR1A (0.36) PDE3BPDE3APRKAB2PRKAG1PRKAA2
SCHEMBL3196394 0.88 HTR1A (0.36) PDE3BPDE3APRKAB2PRKAG1PRKAA2
SCHEMBL3220073 0.87 AQP1 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3
SCHEMBL3207032 0.87 AQP1 (0.39) PRKAB2PRKAG1PRKAA2PRKAA1PRKAG3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF WYETH 2010-02-11 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035871-A1 BENZOXAZINE DERIVATIVES AND USES THEREOF HTR2C, HTR5A, NPY1R KDR 2074/4885PDE3B 718/4885PDE3A 717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.